Check-Cap Ltd. Ord (CHEK) 2.03 $CHEK Check-Cap to

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2016 at 3:02 PM

Check-Cap Ltd. Ord (CHEK) 2.03 $CHEK

Check-Cap to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016
PR Newswire - Wed Sep 07, 6:00AM CDT
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that Bill Densel, Chief Executive Officer, will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13, 2016 at 5:30pm ET in New York City.
CHEK: 2.03 (+0.01)

Check-Cap Reports Second Quarter 2016 Financial Results
PR Newswire - Mon Aug 15, 3:01PM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the second quarter and six months ended June 30, 2016.
CHEK: 2.03 (+0.01)

Check-Cap Ltd. Announces $5.9 Million Financing
PR Newswire - Mon Aug 08, 7:26AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into an agreement with a single health-care focused institutional investor for a registered direct placement of $5.9 million. The Securities Purchase Agreement provides for gross proceeds of $5.9 million, which is comprised of 643,614 ordinary shares, at a purchase price of $1.90 per share and 2,514,281 pre-funded warrants in lieu of ordinary shares, at a purchase price of $1.85 per warrant, which are exercisable for a nominal exercise price (approximately $0.05 per share). In the event that all warrants are exercised, the total gross proceeds to the Company for this financing would be $6.0 million.
CHEK: 2.03 (+0.01)

Check-Cap Announces Agreement with GE Healthcare for X-Ray Capsule Manufacturing Collaboration
PR Newswire - Thu Aug 04, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced it has entered into an agreement with GE Healthcare to develop and validate high-volume manufacturing for X-ray source production and assembly into Check-Cap's capsule. Upon successful completion, the parties may discuss collaboration on execution of a high-volume manufacturing facility and distribution of the Check-Cap system.
CHEK: 2.03 (+0.01)

Check-Cap Awarded $1.25 Million Grant for 2016 From Israel's Office of the Chief Scientist
PR Newswire - Tue Aug 02, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

has awarded the Company a grant of NIS 4.8 million (approximately equivalent to $1.25 million based on the current exchange rate) for 2016. Charged with execution of government policy for support of R&D, the goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel's scientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally.
CHEK: 2.03 (+0.01)

A Win-Win With Check Into Cash: Cash for You and Cash for Kids
PR Newswire - Tue May 31, 11:46AM CDT
This month, don't miss Check Into Cash's Cash For Kids Facebook giveaway benefitting St. Jude Children's Research Hospital. Check Into Cash will match June's $500 giveaway prize with a $500 donation to St. Jude. St. Jude works to advance cures and prevention for pediatric catastrophic diseases, such as cancer, through research and treatment.
CHEK: 2.03 (+0.01)

Check-Cap Announces Preliminary Data Evaluating its Preparation-Free Colon Screening Capsule
PR Newswire - Wed May 25, 7:49AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that preliminary data from pre-clinical and clinical studies were discussed in a podium presentation entitled "A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening" during Digestive Disease Week® (DDW) 2016, taking place in San Diego from May 21-24.
CHEK: 2.03 (+0.01)

Check-Cap Reports First Quarter 2016 Financial Results
PR Newswire - Thu May 19, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the three months ended March 31, 2016.
CHEK: 2.03 (+0.01)

Check-Cap Announces Presentation Evaluating Ingestible Capsule for Preparation-Free Colorectal Cancer Screening at Digestive Disease Week® 2016
PR Newswire - Tue May 17, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced a podium presentation entitled "A Novel Preparation-Free X-Ray Imaging Capsule for Colon Cancer Screening" will be delivered at Digestive Disease Week® (DDW) 2016. The conference is taking place in San Diego from May 21-24.
CHEK: 2.03 (+0.01)

Check-Cap Announces the Publication of Preliminary Clinical Data on its Preparation-Free Colon Screening Capsule in Gut
PR Newswire - Mon Dec 14, 6:00AM CST
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that data related to its clinical studies have been published in Gut, an official peer-reviewed journal of the British Society of Gastroenterology.
CHEK: 2.03 (+0.01)

Check-Cap CEO to Present at LD Micro Main Event on December 2, 2015
PR Newswire - Wed Nov 25, 6:00AM CST
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that Bill Densel, Check-Cap's Chief Executive Officer, will present at the LD Micro 8th Annual Main Event on December 2, 2015 in Los Angeles, CA.
CHEK: 2.03 (+0.01)

Bradley County's Official Halloween Goblin Returns for the 2015 Block Party
Marketwired - Mon Oct 26, 8:02AM CDT
As Halloween draws near, anticipation is building in Cleveland, Tenn. around the 28th annual Halloween Block Party and the spooky appearance of Tall Betsy, Bradley County's official Halloween goblin. Tall Betsy, a 7Â½-foot tall goblin rumored to reside in Fort Hill Cemetery, will make her appearance from 7:30-8 p.m. The Halloween Block Party takes place from 5-10 p.m. on Saturday, October 31 in downtown Cleveland.
CHEK: 2.03 (+0.01)

Check-Cap Featured at the World Endoscopy Organization Colorectal Cancer Screening Committee Meeting
PR Newswire - Mon Oct 26, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that the Check-Cap system was highlighted at the World Endoscopy Organization Colorectal Cancer Screening Committee (WEO CRC SC) Meeting which took place on October 23 in Barcelona, Spain.
CHEK: 2.03 (+0.01)

Check-Cap incurs lower net loss of USD48,000 for Q3 2015
M2 - Fri Oct 23, 5:43AM CDT
Medical diagnostics company Check-Cap (Nasdaq:CHEK)(Nasdaq:CHEKW) stated on Thursday its net loss of USD48,000 for the third quarter ended 30 September 2015.
CHEKW: 0.60 (-0.19), CHEK: 2.03 (+0.01)

Check-Cap Reports Third Quarter 2015 Financial Results
PR Newswire - Thu Oct 22, 6:00AM CDT
Check-Cap Ltd. (the "Company" or "Check-Cap"

(NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced its financial results for the third quarter and nine months ended September 30, 2015. The Company also announced that it will hold its 2015 Annual General Meeting of Shareholders on December 1, 2015.
CHEK: 2.03 (+0.01)

Check-Cap Announces New Data Demonstrating Safety and Detection of Polyps in Clinical Study Evaluating Preparation-Free Colorectal Cancer Screening Capsule
PR Newswire - Tue Oct 20, 5:10AM CDT
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced new data demonstrating safety and polyp detection from a clinical study evaluating the company's non-invasive system for preparation-free examination of the colon. Results will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting taking place October 16-21, 2015 and the United European Gastroenterology Week (UEGW) taking place October 24-28, 2015.
CHEK: 2.03 (+0.01)

Check Into Cash Launches #CheckIntoPink Campaign for Breast Cancer Awareness Month
Marketwired - Thu Oct 01, 6:01AM CDT
Check Into Cash, a national leader in alternative financial services, launches its #CheckIntoPink social campaign today to help spread knowledge about breast cancer. This is the second year in a row that Check Into Cash has participated in Breast Cancer Awareness Month to raise support for women's health. The campaign, which will run throughout October, will lead the audience to CheckIntoCash.com/GoPink, an informational page featuring tips and other educational resources.
CHEK: 2.03 (+0.01)

Check-Cap Announces Appointment of William Densel as Chief Executive Officer and Director
PR Newswire - Thu Aug 13, 8:30AM CDT
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, announced today the appointment of William (Bill) Densel as Chief Executive Officer. The terms of Mr. Densel's engagement as Chief Executive Officer were approved at an extraordinary general meeting of shareholders held today. In addition, Check-Cap's Board of Directors elected Mr. Densel as a director to fill a vacancy on the Board, to serve in such office until the next annual general meeting of shareholders, effective as of the approval of the terms of his engagement as Chief Executive Officer by the Company's shareholders.
CHEK: 2.03 (+0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Communication Works Opens SignlLabs™ AI Licensing

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Fresh Thyme Empowers Local Brands in Michigan Debut

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Wave Kids™ Unveils New Flavors for Kids' Drinks

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Woodpack Global Unveils Crate Design System: A New Era Begins

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

ABC Honors 2026 Spirit of the Heart Leaders

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

LeoLabs and SciTec Partner for $93.7M Space Force Deal

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Maurices Strengthens Position with Key Refinancing Deal

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...